Tachykinin receptors and tachykinin receptor antagonists

10.1111/j.1474-8673.1991.tb00324.x

10.1111/j.1474-8673.1992.tb00341.x

10.1111/j.1474-8673.1989.tb00216.x

10.1016/S0006-291X(05)80041-5

Aharony D., 1992, Pharmacologic characterization of binding of the novel ligand [4,5–3H‐Leu9]NKA to NK‐2 receptors on hamster urinary bladder, FASEB J, 6, Al277

Aimone L. D., 1991, Novel non‐petide substance P antagonists in the rat. Soc, Neurosci. Abst, 17, 805

Al‐Hadithi A. K., 1988, The co‐localisation of substance P and VIP in cholinergic type terminals of the rat parotid gland, J. Anatomy, 159, 83

10.1016/S0006-291X(87)80293-0

Andersson S. E., 1990, Sensory neuropeptides: species variations in effects on the blood‐aqueous barrier regional blood flows and pupillary sphincter muscle, Acta Universitatis Upsaliensis, 263, 1

10.1111/j.1476-5381.1989.tb12583.x

10.1021/jm00109a034

10.1016/0006-8993(86)91514-3

10.1159/000234951

10.1016/0162-3109(89)90057-X

10.1111/j.1476-5381.1986.tb10159.x

10.1111/j.1476-5381.1984.tb10779.x

10.1016/0014-2999(92)90121-J

10.1016/0169-328X(92)90088-S

Baraniuk J. N., 1991, Neuropeptides and nasal secretion, Am. J. Physiol, 261, L223

10.1165/ajrcmb/4.3.228

10.1016/0143-4179(91)90054-M

10.1016/0306-9877(92)90011-Z

10.1016/S0140-6736(86)90777-4

10.1016/0143-4179(92)90356-2

Barnes P. J., 1986, Human bronchial secretion—effect of substance P, muscarinic and adrenergic stimulation in vitro, Br. J. Pharmacol, 89, 767

10.1016/0014-2999(91)90726-7

10.1016/0306-4522(85)90043-0

10.1016/0306-4522(89)90245-5

10.1111/j.1476-5381.1992.tb09061.x

10.1016/0167-0115(89)90261-9

10.1111/j.1476-5381.1991.tb12423.x

Beresford I. J. M., 1992, Investigation into differences in tachykinin NK‐1 receptors between and within species using a peptide and a non‐peptide NK‐1 receptor antagonist, Br. J. Pharmacol, 105, 92P

Bienenstock J., 1989, Mast Cell and Basophil Differentiation and Function in Health and Disease, 275

Birch P. J., 1992, Profile of activity of the NK‐1 receptor antagonist, GR 82,334 in acute nociceptive tests, Br. J. Pharmacol, 105, 134P

10.1111/j.1476-5381.1992.tb09008.x

10.1016/S0006-291X(05)81269-0

Bjorkroth U., 1983, Inhibition of smooth muscle contractions induced by capsaicin and electrical transmural stimulation by a substance P antagonist, Acta Physiol. Scand, 11

10.1016/0014-2999(90)90315-W

Black J. L., 1990, Comparative effects of neurokinin A (NKA) and neuropeptide γ (NPγ) in human isolated bronchus, Clin. Exp. Pharmacol. Physiol, 5

10.1016/0169-328X(87)90031-3

10.1016/0006-8993(85)90386-5

10.1016/0143-4179(92)90365-4

Boyle S. J., 1991, An examination of the selectivity of a new nonpeptide tachykinin antagonist, Br. J. Pharmacol, 104, 146P

10.1164/ajrccm/144.3_Pt_1.630

10.1016/0167-0115(86)90044-3

10.1016/0922-4106(92)90124-E

Brown J. R., 1989, Molecular Recognition: Chemical and Biochemical Problems, 94

10.1016/0143-4179(92)90368-7

10.1111/j.1476-5381.1990.tb15821.x

Bryce D. K., 1991, Differential binding of CP 96,345 across species: possible heterogeneity of the NK‐1 tachykinin receptor, Soc. Neurosci. Abst, 17, 80

10.1126/science.6095447

10.1016/0024-3205(90)90605-Q

10.1016/0196-9781(86)90141-5

10.1016/0024-3205(88)90246-9

10.1016/0197-0186(91)90181-C

Buckner C. K., 1992, Pharmacologic examination of capsaicin‐induced contractions of guinea‐pig isolated trachea, FASEB J, 6, A1366

10.1016/0143-4179(81)90020-2

10.1016/0014-5793(92)80107-R

10.1016/0143-4179(91)90055-N

10.1016/0014-2999(86)90763-6

Burcher E., 1986, Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder, J. Pharmacol. Exp. Ther, 236, 819

Burcher E., 1991, Neuropeptide y‐preferring subtypes of NK‐2 receptors in rat fundus and dog urinary bladder. Soc, Neurosci. Abstr, 17, 805

10.1111/j.1749-6632.1991.tb33101.x

10.1016/0028-3908(91)90165-8

10.1007/BF01966163

10.1007/BF01989769

10.1016/0014-2999(85)90443-1

10.1523/JNEUROSCI.10-07-02203.1990

Cascieri M. A., 1986, Conformationally constrained tachykinin analogs which are selective ligands for the eleidosin binding site, Mol. Pharmacol, 29, 34

10.1007/BF00173591

10.1016/0014-2999(86)90380-8

Chang M. M., 1971, Aminoacid sequence of substance P, Nature, 232, 86

10.1016/0143-4179(91)90137-8

10.1016/0898-5529(90)90065-G

10.1016/0143-4179(92)90375-7

10.1016/0024-3205(83)90060-7

10.1007/BF00172588

Costa M., 1987, Physiology of the Gastrointestinal Tract, 1

10.1007/BF00692914

10.1007/BF00260610

Coy D. H., 1988, Probing peptide backbone function in bombesin, J. Biol. Chem, 11, 5056

10.1111/j.1471-4159.1992.tb09330.x

10.1016/0165-1838(86)90018-4

10.1016/0304-3940(80)90087-7

10.1073/pnas.87.1.246

10.1111/j.1471-4159.1987.tb13138.x

10.1007/BF00428110

10.1016/S0006-291X(05)81343-9

10.1016/0014-2999(91)90808-4

10.1016/0196-9781(85)90143-3

Devillier P., 1989, Respiratory epithelium releases relaxant prostaglandin E2 through activation of substance P (NK1) receptors, Am. Rev. Resp. Dis, 139, A531

10.1111/j.1476-5381.1988.tb11575.x

Devillier P., 1988, Nasal response to substance P and methacholine in subjects with and without allergic rhinitis, Ear. Resp. J, 1, 356, 10.1183/09031936.93.01040356

10.1016/0006-8993(91)91623-9

10.1016/0306-4522(88)90286-2

10.1016/0024-3205(87)90538-8

10.1016/0014-2999(90)90477-N

10.1159/000138717

10.1016/0014-2999(91)90860-S

10.1016/0014-2999(86)90081-6

10.1016/0014-2999(85)90515-1

10.1016/0306-4522(84)90202-1

10.1016/0014-2999(87)90313-X

10.1016/0167-0115(90)90115-D

10.1016/0006-8993(88)90771-8

10.1016/0006-8993(87)90073-4

10.1113/jphysiol.1988.sp017083

10.1016/0165-5728(91)90066-G

10.1016/0014-2999(91)90183-Q

10.1016/0143-4179(92)90391-9

10.1111/j.1476-5381.1989.tb12559.x

10.1113/expphysiol.1988.sp003129

10.1111/j.1748-1716.1982.tb07102.x

10.1016/0304-3940(90)90187-E

10.1016/0006-8993(86)90667-0

10.1016/0006-8993(86)90691-8

Emonds‐Alt X., 1992, A potent and selective nonpeptide antagonist of the neurokinin A (NK‐2) receptor, Life Sci. Pharmacol. Letters, 50, 01

10.1016/0166-2236(81)90084-9

10.1002/jcp.1041450113

10.1016/0143-4179(92)90394-C

Fardin V., 1992, Binding profile of RP 67,580, a new non‐peptide SP antagonist: comparison with CP 96,345, Br. J. Pharmacol, 105, 80

10.1016/0014-2999(91)90350-Y

10.1007/BF00581499

10.1113/jphysiol.1986.sp016260

10.1016/0166-2236(89)90161-6

Fleetwood‐Walker S. M., 1991, Effect of antagonists selective for NK‐1 and NK‐2 receptors on somatosensory responses of rat dorsal horn neurones, Br. J. Pharmacol, 104, 472P

10.1016/0006-8993(90)90075-M

Flowers J. M., 1991, NK‐1 and NK‐2 neurokinin receptors characterized in the rat isolated urinary bladder preparation, Br. J. Pharmacol, 104, 149P

10.1111/j.1476-5381.1984.tb16506.x

Folkers K., 1985, Tachykinin Antagonists, 259

Fong T. M., 1992, Differential activation of intracellular effector by two isoforms of human neurokinin 1 receptor, Mol. Pharmacol, 41, 24

10.1111/j.1748-1716.1991.tb09240.x

10.1016/0306-4522(88)90236-9

Frossard N., 1991, Tachykinin receptors and the airwarys, Life Sci, 19541

10.1016/0143-4179(92)90399-H

10.1016/0014-2999(91)90103-W

10.1113/jphysiol.1984.sp015219

10.1113/jphysiol.1990.sp017911

10.1016/0304-3940(87)90123-6

10.1016/0024-3205(79)90558-7

Gamse R., 1981, Immunoreactive substance P in sympathetic ganglia: distribution and sensitivity toward capsaicin, Neuro-science, 6, 437

10.1016/0006-8993(86)91347-8

10.1073/pnas.88.22.10208

Garret C., 1992, RP 67,580 a potent and selective non‐peptide SP antagonist, C. R. Acad. Sci. Paris, 314, 199

10.1016/0024-3205(91)90120-Z

Geraghty D. P., 1991, Radioiodinated substance P, neurokinin A and eledoisin bind predominantly to NK‐1 receptors in guinea‐pig lung, Mol. Pharmacol, 41, 147

10.1016/0304-3940(90)90216-V

Gerard N. P., 1990, The human neurokinin A (substance K) receptor, J. Biol. Chem, 265, 20455

10.1021/bi00108a006

10.1016/0014-5793(92)80295-R

10.1016/0006-291X(88)90444-5

10.1016/0014-2999(91)90532-U

10.1016/0014-2999(91)90892-T

10.1016/0143-4179(92)90404-K

10.1016/0014-2999(88)90022-2

Giuliani S., 1988, Neurokinins induce a relaxation of the rat duodenum in vivo by activating postganglionic sympathetic elements in prevertebral ganglia: involvement of an NK‐2 type of neurokinin receptor, J. Pharmacol. Exp. Ther, 246, 322

10.1016/0143-4179(92)90405-L

10.1113/jphysiol.1987.sp016731

10.1007/BF01540348

10.1016/0006-291X(91)91940-E

Growcott J. W., 1980, Differences between central and peripheral actions of substance P and substance P (1–9) nonapeptide, Br. J. Pharmacol, 77, 504P

10.1016/0006-291X(91)91344-C

Guard S., 1992, Interaction of the non‐peptide NK‐1 tachykinin receptor antagonist (|Mp)CP 96,345 with L‐type calcium channels in rat cerebral cortex, Br. J. Pharmacol, 106, 37P

10.1016/0197-0186(91)90180-L

Guard S., 1991, [125I] Neuropeptide‐y and [125I] iodohistidyl‐neurokinin A label multiple tachykinin receptors in rat brain, Br. J. Pharmacol, 104, 229P

10.1111/j.1748-1716.1987.tb08146.x

Hagan R. M., 1991, A spirolactam conformationally‐constrained analogue of physalaemin which is a peptidase resistant, selective NK‐1 receptor agonist, Br. J. Pharmacol, 102, 168P

10.1111/j.1476-5381.1990.tb14685.x

10.1016/0014-2999(91)90086-6

Hagiwara D., 1991, The discovery of a tripeptide substance P antagonist and its structure‐activity relationship, J. Pharmacobio. Dyn, 14, s104

10.1111/j.1476-5381.1982.tb09348.x

10.1016/0006-8993(87)90242-3

10.1016/0167-0115(88)90297-2

10.1111/j.1476-5381.1991.tb12202.x

Harbeson S. L., 1990, Peptides, Chemistry, Structure and Biology, 180, 10.1007/978-94-010-9060-5_54

Hartung H. P., 1988, Substance P and astrocytes: stimulation of the cyclooxygenase pathway of arachidonic acid metabolism, FASEB J, 2, 48, 10.1096/fasebj.2.1.2446942

10.1007/BF00165629

10.1111/j.1748-1716.1975.tb10058.x

10.1096/fasebj.4.6.1969374

Helme R. D., 1987, The effect of substance P on the regional lymphonode antibody response to antigenic stimulation in capsaicin‐pretreated rats, J. Immunol, 139, 3470, 10.4049/jimmunol.139.10.3470

10.1016/0304-3940(86)90373-3

10.1016/0922-4106(92)90099-H

10.1007/978-1-4612-4672-5

10.1126/science.2154852

10.1111/j.1748-1716.1981.tb06943.x

10.1126/science.6171036

10.1016/0306-4522(88)90064-4

Holzer P., 1989, Ascending enteric reflex: multiple neurotransmitter systems and interactions, Am. J. Physiol, 256, G540

10.1111/j.1476-5381.1986.tb11144.x

Holzer P., 1991, Sensory neurons mediate protective vasodilatation in rat gastric mucosa, Am. J. Physiol, 260, G363

10.1016/0016-5085(86)90702-X

10.1016/0143-4179(92)90417-U

10.1007/BF00499905

10.1164/ajrccm/143.6.1416

Hong J. S., 1983, Effects of lithium and haloperidol administration on the rat brain levels of substance P, J. Pharmacol. Exp. Ther, 224, 590

10.1016/S0006-291X(05)81181-7

10.1159/000235396

10.1007/BF00512072

10.1016/0306-4522(86)90024-2

10.1016/0167-0115(85)90082-5

10.1002/syn.890060102

10.1016/0014-2999(91)90387-6

Igwe O. J., 1990, Specific binding of substance P aminoterminal heptapeptide [SP(1–7)] to mouse brain and spinal cord membranes, J. Neuroscience, 10, 3653, 10.1523/JNEUROSCI.10-11-03653.1990

Ingi T., 1992, Characterization of ligand‐binding properties and selectivities of three rat tachykinin receptors by transfection and functional expression of their cloned cDNAs in mammalian cells, J. Pharmacol. Exp. Ther, 259, 968

10.1016/0006-8993(85)90499-8

10.1111/j.1476-5381.1991.tb09812.x

Ireland S. J., 1992, Comparison of the apparent affinity of GR 82,334 at NK‐1 receptors in various tissue preparations, Br. J. Pharmacol, 106, 93P

10.1016/0167-0115(88)90313-8

Iversen L. L., 1985, The possible role of neuropeptides in the pathophysiology of rheumatoid arthritis, J. Rheumatology, 12, 399

10.1177/026988118900300101

Iversen L. L., 1990, Neuropepiides and their Receptors, 363

10.1016/0304-3940(89)90552-1

10.1007/BF00168965

Janiszewski J., 1992, Mast cells show electrophysiological response to very low levels of substance P without degranulation, FASEB J, 6, A1613

Jensen R. T., 1988, Characterization of the ability of various substance P antagonists to inhibit action of bombesin, Am. J. Physiol, 254, G883

10.1038/309061a0

10.1007/BF00251127

10.1007/978-1-4612-4672-5_5

10.1111/j.1748-1716.1986.tb07783.x

10.1016/0024-3205(91)90045-D

10.1016/0196-9781(89)90166-6

Kage R., 1991, Characterization of the substance P receptor in tunicamycin‐treated transfected cells using a photoaffinity analog, Soc. Neurosci. Abst, 17, 805

10.1016/0149-7634(85)90004-1

10.1016/0168-0102(84)90009-9

10.1007/BF00496372

10.1126/science.6169153

10.1016/0006-8993(83)91240-4

10.1016/0006-8993(88)90644-0

10.1113/jphysiol.1990.sp018282

10.1136/ard.49.8.649

10.1016/0196-9781(91)90011-D

10.1016/0167-0115(91)90054-K

10.1007/BF01296290

10.1159/000235449

10.1111/j.1748-1716.1983.tb07192.x

Konturek S. J., 1981, Effect of substance P and its C‐terminal hexapeptide on gastric and pancreatic secretion in the dog, Am. J. Physiol, 241, G74

10.1073/pnas.83.18.7074

10.1016/0304-3940(87)90164-9

10.1073/pnas.84.3.881

10.1073/pnas.82.14.4832

Kris R., 1991, Cloning and expression of the human substance K receptor and analysis of its role in mitogenesis, Cell Growth and Differentiation, 2, 15

10.1016/0143-4179(92)90516-Y

10.1016/0006-8993(85)90326-9

10.1007/BF00489970

Kuwahara A., 1990, Tachykinin‐induced anion secretion in guinea‐pig distal colon: role of neural and inflammatory mediators, J. Pharmacol. Exp. Ther, 252, 1

10.1136/ard.48.11.928

10.1007/BF01997623

10.1073/pnas.82.21.7444

Lavielle S., 1990, Selective agonists of tachykinin binding sites. Fund, Clin. Pharmacol, 4, 257

10.1038/294467a0

10.1016/0143-4179(92)90438-3

10.1016/0304-3940(91)90485-C

10.1007/BF00501166

10.1016/0014-2999(86)90270-0

10.1111/j.1476-5381.1992.tb14243.x

10.1016/0143-4179(81)90013-5

10.1111/j.1476-5381.1992.tb09013.x

10.1007/BF00538551

10.1126/science.6208609

10.1016/0014-2999(90)90670-2

10.1016/0014-2999(92)90647-M

10.1016/0143-4179(85)90144-1

10.1016/0167-0115(85)90016-3

10.1016/0304-3940(86)90421-0

10.1016/0167-0115(88)90097-3

10.1111/j.1476-5381.1989.tb11788.x

10.1016/0197-0186(88)90178-7

10.1111/j.1471-4159.1991.tb06408.x

10.1111/j.1749-6632.1991.tb33113.x

10.1016/0165-3806(88)90002-8

10.1007/BF02463647

10.1016/0143-4179(92)90442-Y

10.1126/science.2433770

10.1126/science.2457950

10.1111/j.1748-1716.1992.tb09290.x

10.1007/BF00217848

10.1111/j.1748-1716.1991.tb09060.x

10.1111/j.1748-1716.1983.tb07304.x

10.1146/annurev.ph.49.030187.003013

10.3109/00016488309132735

MacDonald M. R., 1989, Multiple tachykinins are produced and secreted upon posttranslational processing of the three substance P precursor proteins, α‐, β‐ and γ‐preprotachykinin, J. Biol. Chem, 264, 15578, 10.1016/S0021-9258(19)84871-8

McKnight A. T., 1991, Pharmacological specificity of novel, synthetic, cyclic peptides as antagonists at tachykinin receptors, Regul. Pharmacol, 104, 335

10.1016/0167-0115(88)90347-3

10.1126/science.1703324

Maggi C. A., 1990, Capsaicin‐sensitive nerves in the gastrointestinal tract, Arch. Int. Pharmacodyn. Ther, 303, 157

10.1016/S1043-6618(05)80045-3

10.1111/j.1474-8673.1991.tb00317.x

Maggi C. A., 1991, The role of peptides in the regulation of micturition reflex: an update. Gen, Pharmacol, 22, 1

10.1016/0024-3205(92)90047-S

10.1016/S0022-5347(17)39796-3

10.1016/S0022-5347(17)38701-3

10.1007/BF00169311

10.1016/0167-0115(92)90657-G

10.1016/0306-4522(88)90140-6

Maggia C. A., 1991, In vivo evidence for tachykininergic transmission using a new NK‐2 receptor selective antagonist. MEN 10376, J. Pharmacol. Exp. Ther, 257, 1172

10.1016/0014-2999(90)90552-H

Maggi C. A., 1986, Motor effect of neurokinins on the rat duodenum: evidence for the involvement of substance K and substance P receptors, J. Pharmacol. Exp. Ther, 238, 341

10.1016/0016-5085(92)91787-5

10.1016/S0022-5347(17)38287-3

10.1016/0014-2999(85)90750-2

10.1111/j.1474-8673.1987.tb00153.x

10.1016/0306-3623(88)90002-X

Maggi C. A., 1988, Neurokinin receptors in the rat lower urinary tract, J. Pharmacol. Exp. Ther, 246, 308

10.1111/j.1476-5381.1992.tb14430.x

10.1016/0143-4179(92)90061-Z

10.1111/j.1749-6632.1991.tb33106.x

10.1111/j.1474-8673.1990.tb00016.x

10.1111/j.1476-5381.1992.tb14459.x

10.1016/0014-2999(91)90648-A

10.1111/j.1476-5381.1990.tb14195.x

10.1111/j.1476-5381.1990.tb15851.x

10.1007/BF00195061

10.1007/BF00178976

10.1016/0014-2999(91)90517-T

Maggi C. A., 1991, Tachykinin receptor antagonists and potential clinical applications at peripheral level. Biochem, Soc. Transactions, 19, 909

10.1016/0014-2999(89)90356-7

10.1164/ajrccm/144.2.363

10.1111/j.1476-5381.1991.tb09823.x

10.1007/BF00736056

10.1007/BF00169740

10.1016/0306-3623(89)90104-3

Maggi C. A., 1986, Activation of micturition reflex by substance P and substance K: indirect evidence for the existence of multiple tachykinin receptors in the rat urinary bladder, J. Pharmacol. Exp. Ther, 238, 259

10.1111/j.2042-7158.1985.tb05042.x

10.1016/0014-2999(88)90438-4

10.1016/0306-4522(92)90143-P

10.1016/0306-4522(90)90266-7

10.1016/0196-9781(85)90380-8

Main M. J., 1991, Neurokinin receptors subtypes mediating the depolarization of neurones in rat and guinea‐pig superior cervical ganglia are different, Br. J. Pharmacol, 101, 471P

10.1016/0196-9781(89)90154-X

Mantyh P. W., 1989, Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues, J. Neuro science, 9, 258

10.1073/pnas.85.9.3235

10.1073/pnas.86.13.5193

10.1111/j.1476-5381.1992.tb09086.x

Mapp C. E., 1991, Toluene diisocyanate contracts guinea‐pig bronchial smooth muscle by activating capsaicin‐sensitive sensory nerves, J. Pharmacol. Exp. Ther, 256, 1082

10.1016/0306-4522(90)90199-E

10.1111/j.1749-6632.1991.tb33147.x

10.1016/0006-291X(81)90727-0

Marchand J. E., 1990, Disulfiram administration affects substance P‐like immunoreactive & monoaminergic neural systems in rodent brain, J. Biol. Chem, 265, 264, 10.1016/S0021-9258(19)40225-1

10.1016/0006-8993(91)90808-9

10.1523/JNEUROSCI.07-12-04129.1987

10.1002/cne.903170403

10.1016/0024-3205(87)90130-5

10.1007/BF00165803

10.1016/0006-8993(90)91082-R

10.1016/0014-2999(87)90363-3

10.1038/329836a0

10.1016/0024-3205(89)90162-8

Mitsuhashi M., 1992, Multiple intracellular signaling pathways of the substance P receptor, FASEB J, 6, A10562

10.1016/0014-2999(85)90659-4

10.1016/0014-2999(84)90241-3

Morrison J. F. B., 1990, The effect of neonatal capsaicin treatment on the distribution of neurokinin binding sites in rat bladder, J. Physiol. (London), 423, 79P

10.1007/BF01642901

10.1016/0165-6147(90)90179-C

10.1016/0196-9781(87)90182-3

Murray C. W., 1987, Neurokinin‐induced salivation in the anesthetized rat: a three receptor hypothesis, J. Pharmacol. Exp. Ther, 242, 500

10.1016/0196-9781(90)90200-O

10.1111/j.1749-6632.1991.tb33152.x

Nadel J. A., 1991, Neutral endopeptidase modulates neurogenic inflammation, Eur. Resp. J, 4, 745, 10.1183/09031936.93.04060745

Nakajima Y., 1992, Direct linkage of three tachykinin receptors to stimulation of both phopshatidylinositol hydrolysis & cyclic ASMP cascades in transfected Chinese hamster ovary cells, J. Biol. Chem, 267, 2437, 10.1016/S0021-9258(18)45898-X

10.1146/annurev.ne.14.030191.001011

10.1164/ajrccm/140.3.679

10.1007/978-1-4615-9546-5_66

10.1097/00005344-199109000-00013

10.1016/0014-2999(90)90189-D

10.1016/0024-3205(84)90087-0

10.1038/306032a0

10.1038/312729a0

Nieber K., 1991, The possible role of substance P in the allergic reaction based on two different provocation models. Int. Arch. Allergy Appl, Immunol, 94, 334

10.1038/315061a0

10.1016/0143-4179(92)90460-E

10.1016/0167-0115(84)90076-4

10.1016/0006-8993(85)91423-4

10.1016/0304-3940(87)90316-8

Ollerenshaw S. L., 1991, Substance P immunoreactive nerves in airways from asthmatics & nonasthmatics, Eur. Resp. J, 4, 673, 10.1183/09031936.93.04060673

10.1113/jphysiol.1988.sp016917

10.1007/BF00711176

10.1016/0014-2999(92)90251-X

10.1016/0304-3959(87)90041-8

10.1016/S0022-5347(17)39795-1

Parsons A. M., 1992, Neurokinin receptors & mucosal ion transport in porcine jejunum, J. Pharmacol. Exp. Ther, 261, 1213

10.1016/0143-4179(91)90060-V

10.1111/j.1476-5381.1991.tb12390.x

Patacchini R., 1992, Effect of newly developed tachykinin agonists & antagonists on the guinea‐pig isolated gallbladder, J. Pharmacol. Exp. Ther, 201, 191

Patacchini R., 1991, Effect of newly developed tachykinin agonist & antagonists on the guinea‐pig isolated gallbladder, Br. J. Pharmacol, 145P

Patacchini R., 1989, Effect of thiorphan on tachykinininduced potentiation of nerve‐mediated contractions of the rat isolated vas deferens, J. Pharmacol. Exp. Ther, 250, 678

10.1016/0014-2999(92)90613-9

Payan D. G., 1983, Specific stimulation of human T lymphocytes by substance P, J. Immunology, 131, 1613, 10.4049/jimmunol.131.4.1613

10.1016/0167-0115(87)90036-X

Pereira da silva J. A., 1990, Peptide containing nerves in human synovium: immunohistochemical evidence for decreased innervation in rheumatoid arthritis, J. Rheumatol, 17, 1592

Pernow B., 1983, Substance P, Pharmacol. Rev, 35, 85

10.1007/978-1-4612-4672-5_123

10.1016/0014-2999(91)90913-B

10.1016/0167-0115(82)90057-X

10.1016/0024-3205(85)90198-5

10.1016/0143-4179(92)90470-H

Poosch M. S., 1991, Distribution of neurokinin receptor gene expression in the rat brain, Soc. Neurosci. Ahst, 17, 806

10.1016/0196-9781(88)90258-6

10.1016/0014-2999(85)90008-1

10.1016/0143-4179(92)90475-C

10.1016/0143-4179(85)90090-3

Radhakrishnan V., 1991, Novel substance P antagonist CP‐96,354, blocks responses of cat spinal dorsal horn neurons to noxious cutaneous stimulation & to substance P. Neurosci, Letters, 132, 39

10.1161/01.RES.66.5.1178

Rangachari P. K., 1990, Epithelial & mucosal preparations from canine colon: responses to substance P, J. Pharmacol. Exp. Ther, 254, 1076

10.1016/0165-6147(85)90228-7

10.1016/0165-6147(88)90013-2

10.1016/0024-3205(87)90349-3

10.1159/000138512

10.1016/0014-2999(84)90449-7

10.1159/000137979

10.1016/0014-2999(85)90548-5

Renzetti L. M., 1992, Nonadrenergic noncholinergic (NANC) contractile responses of the guinea‐pig hilar bronchus are partially mediated by tachykinin NK‐2 receptors, FASEB J, 6, A1366

Rhoden K. J., 1990, Classification of tachykinin receptors in guinea‐pig & human airway smooth muscle, Am. Rev. Resp. Dis, 141, A726

10.1073/pnas.84.14.5078

10.1016/0028-3908(83)90005-9

10.1016/0014-2999(89)90322-1

10.1016/0014-2999(91)90016-J

10.1111/j.1748-1716.1983.tb00019.x

10.1016/0165-6147(82)91095-1

Rouissi N., 1991, Selectivity & specificity of new, non‐peptide quinuclidine antagonists of substance P. Biochem. Biophys. Res, Comm, 176, 894

10.1016/0196-9781(91)90053-R

10.1016/0143-4179(92)90062-2

10.1016/0014-2999(90)90161-X

10.1016/0196-9781(90)90067-F

10.1016/0143-4179(89)90080-2

10.1016/0196-9781(92)90164-X

10.1016/0014-2999(92)90335-2

10.1016/0196-9781(88)90255-0

Saito R., 1990, Characterization of tachykinin receptors in endothelial cells of porcine artery. Neurosci, Letters, 110, 337

10.1002/ana.410240607

10.1016/0306-4522(91)90229-H

10.1016/0304-3940(88)90671-4

Sakurada T., 1991, Differential effects of substance P analogs on NK‐1 receptor agonists in the mouse spinal cord, J. Pharmacol. Exp. Ther, 259, 205

10.1021/jm00351a001

10.1111/j.1476-5381.1984.tb16461.x

10.1016/0304-3940(86)90376-9

10.1164/ajrccm/137.6.1330

10.1016/0014-2999(84)90699-X

Sasai Y., 1989, Molecular characterization of rat substance K receptor & its mRNA. Biochem. Biophys, Res. Comm, 165, 695

10.1016/0006-8993(90)90830-5

Schepp W., 1990, Effect of substance P & neurokinin A on rat parietal cell function, Am. J. Physiol, 259, G646

10.1016/0196-9781(91)90045-Q

10.1016/0024-3205(85)90269-3

10.1111/j.1476-5381.1992.tb09079.x

10.1016/0006-8993(84)90346-9

Shibata K., 1990, Tachykinin gene expression in rat limbic nuclei: modulation by dopamine antagonists, J. Pharmacol. Exp. Ther, 255, 388

Shigemoto R., 1990, Cloning & expression of a rat neuromedin K receptor cDNA, J. Biol. Chem, 265, 623, 10.1016/S0021-9258(19)40095-1

10.1016/0143-4179(91)90070-Y

10.1126/science.1703323

10.1073/pnas.88.22.10042

10.1152/jappl.1991.71.6.2077

10.1164/ajrccm/141.6.1538

10.1016/0167-0115(91)90159-E

Stables J. M., 1992, Tachykinins can depolarize the rat isolated superior cervical ganglion via NK‐1 receptors, Br. J. Pharmacol, 105, 250P

10.1016/0016-5085(89)90627-6

10.1016/0014-2999(86)90245-1

10.1016/0016-5085(89)90070-X

10.1007/BF00172963

10.1016/0143-4179(92)90498-L

10.1111/j.1476-5381.1992.tb09071.x

Sundelin J. B., 1992, Molecular cloning of the murine substance K & substance P receptor genes. Eur, J. Biochem, 203, 625

10.1016/B978-0-08-027350-1.50009-8

10.1016/0304-3940(82)90183-5

Takano Y., 1991, Tachykinin receptor subtypes: cardiovascular roles of tachykinin peptides, Asia Pacific J. Pharmacol, 6, 341

10.1016/0006-8993(90)91662-Z

10.1016/0006-291X(91)91704-G

Takeda Y., 1989, Characterization of a high affinity neuropeptide γ binding site in rat duodenum, urinary bladder & vas deferens, Soc. Neurosci. Abstr, 15, 346

10.1073/pnas.86.1.392

10.1016/0014-2999(89)90858-3

10.1111/j.1749-6632.1991.tb33163.x

10.1016/0167-0115(90)90030-Z

Taniguchi T., 1986, Levels of neurokinin A, neurokinin B and substance P in rabbit iris sphincter muscle. Japn, J. Pharmacol, 42, 590

10.1016/0167-0115(90)90094-D

10.1016/0006-291X(85)90138-X

10.1111/j.1476-5381.1992.tb09036.x

10.1111/j.1432-1033.1987.tb13567.x

10.1016/0006-291X(85)91772-3

10.1113/jphysiol.1991.sp018599

10.1016/0196-9781(89)90070-3

10.1016/0167-0115(89)90001-3

10.1111/j.1471-4159.1988.tb02466.x

10.1016/0167-0115(90)90062-2

10.1016/0024-3205(90)90386-6

10.1016/0006-8993(91)91207-H

Tsuchida K., 1990, Tissue distribution and quantification of the mRNA for three rat tachykinin receptors. Eur, J. Biochem, 193, 751

Turner A. J., 1987, Neuropeptides and theirPeptidases, Ellis Horwood Series in Biomedicine, Chichester

10.1016/0143-4179(92)90507-S

Van Giersbergen P. L. M., 1992, Comparison of the effects of neuropeptide K and neuropeptide y with neurokinin A at NK‐2 receptors in the hamster urinary bladder. Naunyn Schmiedeberg's Arch, Pharmacol, 345, 51

10.1111/j.1749-6632.1991.tb33164.x

10.1073/pnas.88.5.1661

Vigna S. R., 1989, Substance P receptors on canine chief cells: localization, characterization and function, J. Neuroscience, 9, 2878, 10.1523/JNEUROSCI.09-08-02878.1989

10.1113/jphysiol.1931.sp002763

10.1111/j.1748-1716.1974.tb05631.x

10.1016/0167-0115(87)90177-7

10.1016/0014-2999(85)90003-2

Walsh D. M., 1991, Characterization of neurokinin receptors in the mouse which mediate antidipsogenic activity, Br. J. Pharmacol, 104, 473P

10.1016/0306-3623(92)90016-D

10.1021/jm00169a003

Watson S. P., 1983, Pharmacological characterization of a substance P antagonist [D‐Arg1, D‐Pro2, D‐Trp7,9, Leu11] substance P. Br, J. Pharmacol, 80, 205

10.1016/0304-3940(91)90108-6

Weihe E., 1989, Tachykinins, CGRP & neuropeptide Y in nerves of the mammalian thymus: interactions with mast cells in autonomic and sensory neuroimmunomodulation? Neurosci, Letters, 100, 77

10.1111/j.1749-6632.1991.tb33116.x

10.1007/978-3-0348-9136-3_16

10.1111/j.1476-5381.1989.tb12639.x

10.1016/0167-0115(88)90409-0

10.1016/0196-9781(92)90109-G

10.1016/0304-3940(92)90564-N

10.1016/0306-4522(91)90071-U

Xu X. J., 1991, On the role of NK‐1 and NK‐2 tachykinin receptors in mediation of spinal cord reflex excitability. Soc, Neurosci. Abst, 17, 728

10.1016/0024-3205(91)90637-Q

10.1016/0006-8993(88)90474-X

10.1126/science.2218531

10.1007/BF00170652

Yokota Y., 1989, Molecular characterization of a functional cDNA for rat substance P receptor, J. Biol. Chem, 264, 17469, 10.1016/S0021-9258(19)84619-7

Yonehara N., 1987, Contribution of substance P to heat‐induced edema in rat paw, J. Pharmacol. Exp. Ther, 242, 1071

Ziche M., 1991, Substance P induces migration of capillary endothelial cells: a novel NK‐l‐selective receptor mediated activity, Life Sci. Pharmacology Letters, 48

10.1111/j.1476-5381.1990.tb12043.x

10.1016/0026-2862(90)90024-L

10.1113/jphysiol.1991.sp018897